All articles tagged with #pain treatment
Originally Published 3 months ago — by Nature
Scientists discovered a specific brain cell group in mice linked to persistent pain, which could lead to new treatments for chronic pain in humans, by manipulating neuropeptide Y signaling to reduce pain perception.
Originally Published 4 months ago — by The Economist
Scientists have discovered a gene linked to chronic pain, potentially paving the way for new, more effective treatments for the over 600 million people affected worldwide, as current understanding and therapies remain limited.
Originally Published 6 months ago — by The Jerusalem Post
A new study from Hebrew University reveals that paracetamol not only acts in the brain but also directly blocks pain at its source by targeting sodium channels in nerve endings, opening new avenues for safer, more targeted pain treatments.
Originally Published 7 months ago — by buzzfeed.com
Many women share experiences of having their serious pain dismissed or underestimated in emergency rooms, highlighting systemic gender biases and the need for better recognition and treatment of women's health concerns.
Originally Published 2 years ago — by VOA Learning English
Ketamine, a drug traditionally used as a painkiller during surgery, is increasingly being used as a treatment for pain, depression, anxiety, and other conditions. However, experts express concerns about the lack of research on its effectiveness and the potential for abuse and safety risks. Studies have shown that ketamine can have significant side effects, including hallucinations and visual problems. The use of ketamine has surged in recent years, with prescriptions increasing over 500%. Online health services have also made it easier to obtain ketamine prescriptions. The FDA has warned against mixed versions of ketamine due to safety concerns.
Originally Published 2 years ago — by Yahoo Canada Shine On
Ketamine, a mind-altering drug, is being used as a pain treatment despite limited research and regulation. The drug, originally developed as an anesthetic, has gained popularity for its potential to alleviate chronic pain. However, concerns have been raised about its long-term effects and the lack of standardized protocols for its use. While some experts believe ketamine can be a valuable tool in pain management, others caution that more research is needed to fully understand its risks and benefits.
Originally Published 2 years ago — by New York Post
Ketamine, a decades-old surgical drug, is experiencing a surge in prescriptions as a treatment for pain, depression, anxiety, and other conditions. The increase in its use is driven by for-profit clinics and telehealth services, despite limited research on its effectiveness and significant safety and abuse risks. Some experts fear that the U.S. may be repeating the mistakes that led to the opioid crisis by overprescribing a drug with questionable benefits. Ketamine's psychedelic effects and potential for side effects, such as hallucinations and visual disturbances, raise concerns. The booming industry lacks regulation, and compounded versions of ketamine are being used without FDA approval. While there is evidence for ketamine's use in depression, its effectiveness for pain treatment is uncertain.
Originally Published 2 years ago — by Honolulu Star-Advertiser
Ketamine, a decades-old surgical drug now used as a psychedelic therapy, is increasingly being prescribed for hard-to-treat pain, depression, anxiety, and other conditions. However, there is limited research on its effectiveness against pain, and experts are concerned about the potential for overprescribing a drug with significant safety and abuse risks. Patients receiving ketamine have reported side effects such as hallucinations and visual disturbances, and it has not been shown to reduce opioid prescribing. The booming ketamine industry, fueled by venture capital investors, for-profit clinics, and telehealth services, operates in a regulatory "wild west" with little oversight.
Originally Published 2 years ago — by ABC News
Ketamine, a decades-old surgical drug known for its psychedelic effects, is increasingly being prescribed as a treatment for hard-to-treat pain, depression, anxiety, and other conditions. However, there is limited research on its effectiveness against pain, and some experts are concerned about the potential for overprescribing a drug with significant safety and abuse risks. Patients receiving ketamine have reported side effects such as hallucinations and visual disturbances, and it has not been shown to reduce opioid prescribing rates. The booming ketamine industry, driven by for-profit clinics and telehealth services, has led to shortages of manufactured ketamine and a rise in compounded versions. While there is more evidence for ketamine's use in depression, its use for pain is not well-supported by scientific literature. The current regulatory landscape is described as a "wild west," with little oversight over prescribing practices and compounded versions of ketamine.
Originally Published 2 years ago — by Yahoo News
Ketamine, a decades-old surgical drug known for its psychedelic effects, is increasingly being prescribed as a treatment for hard-to-treat pain, depression, anxiety, and other conditions. However, there is limited research on its effectiveness against pain, and experts are concerned about the potential for overprescribing a drug with significant safety and abuse risks. Patients receiving ketamine have reported side effects such as hallucinations and visual disturbances, and it has not been shown to reduce opioid prescribing rates. The booming ketamine industry, driven by for-profit clinics and telehealth services, operates in a regulatory gray area, with compounded versions of the drug being sold without FDA approval. Despite warnings from the FDA, the agency has limited leverage over physicians promoting ketamine, and it is unlikely that regulators will take further action in the near future.